The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by CRANE, D. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by CRANE, D. L.
Related Collections
* Neurotransmitters
* Schizophrenia Spectrum Disorders
Am J Psychiatry 161:376, February 2004
© 2004 American Psychiatric Association


Letter to the Editor

On Biology, Phenomenology, and Pharmacology in Schizophrenia

DANIEL L. CRANE, M.D.
New York, N.Y.

To the Editor: In a recent issue of the Journal, Shitij Kapur, M.D., Ph.D., F.R.C.P.C., described the linkage between biology, phenomenology, and pharmacology in schizophrenia (1). Two articles in the British literature from 1961 (2) and 1966 (3) seem to dovetail nicely with Dr. Kapur’s elegantly crafted framework.

The British authors argued against Federn’s 1953 theoretical model of psychosis (4) as an impairment of ego functions and suggested that the breakdown in interpersonal difficulties was a reaction to a primary cognitive disturbance in the field of attention and perception and that all schizophrenia symptom profiles could be interpreted as reactions to this basic disorder. Their methods consisted of meticulously recording clinical interviews with schizophrenia patients. They were not aware of the central role of dopamine in reward and reinforcement. Thus, they were not able to describe the reported abnormalities of perception in terms of aberrant salience rather than as phenomenological entities alone.

Dr. Kapur’s convincing hypothesis presents strong experimental, pharmacological, and neurobiological data to help one understand the mass of schizophrenia phenomenology previously described and ascribed to varying, now presumably incorrect, hypotheses.

References

  1. Kapur S: Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160:13–23[Abstract/Free Full Text]
  2. McGhie A, Chapman J: Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961; 34:103–116[Medline]
  3. Chapman J: The early symptoms of schizophrenia. Br J Psychiatry 1966; 112:225–251[Abstract/Free Full Text]
  4. Federn P: Ego Psychology and the Psychosis. London, Imago, 1953




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by CRANE, D. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by CRANE, D. L.
Related Collections
* Neurotransmitters
* Schizophrenia Spectrum Disorders


Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org